✦ LIBER ✦

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery

✍ Scribed by Oliyai, Reza; Stella, Valentino J.

Book ID: 120461678
Publisher: Annual Reviews
Year: 1993
Tongue: English
Weight: 703 KB
Volume: 33
Category: Article
ISSN: 0362-1642
DOI: 10.1146/annurev.pa.33.040193.002513

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[ACS Symposium Series] Formulation and D

[ACS Symposium Series] Formulation and Delivery of Proteins and Peptides Volume 567 || Formulation and Delivery of Proteins and Peptides, Copyright, 1994 Advisory Board, Foreword

✍ Cleland, Jeffrey L.; Langer, Robert 📂 Article 📅 1994 🏛 American Chemical Society ⚖ 314 KB

Formulation technologies to overcome unf

Formulation technologies to overcome unfavorable properties of peptides and proteins for pulmonary delivery

✍ Feng Wan; Eva Horn Møller; Mingshi Yang; Lene Jørgensen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 255 KB

ChemInform Abstract: Formulation and Del

ChemInform Abstract: Formulation and Delivery of Proteins and Peptides. Design and Development Strategies.

✍ J. L. CLELAND; R. LANGER 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB

Formulation Development and Drug Deliver

Formulation Development and Drug Delivery Systems for Protein and Peptide Drug Products

📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 322 KB

Formulation Development and Drug Deliver

Formulation Development and Drug Delivery Systems for Protein and Peptide Drug Products

📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 491 KB

Delivery Technologies for Biopharmaceuti

Delivery Technologies for Biopharmaceuticals || Novel Formulation Approaches for Peptide and Protein Injectables

✍ Jorgensen, Lene; Nielsen, Hanne Mrck 📂 Article 📅 2009 🏛 John Wiley & Sons, Ltd 🌐 English ⚖ 172 KB

Advances in biotechnology have provided scientists with an increasing number of biopharmaceuticals such as novel peptide and protein drugs as well as nucleic acid based drugs for gene therapy. However, successful delivery of these biopharmaceuticals is a major challenge because their molecular prope